Abstract
The controversial point of treatment for oropharyngeal cancer is the surgical approach and it is in transition, especially for resectable tumors. Transcervical oropharyngectomy with mandibulotomy is an oncologically valid surgical option for resectable T3–T4a oropharyngeal cancers and contraindications for transoral lateral oropharyngectomy. The approach without mandibulotomy allows for simple reconstruction and has a low complication rate. In particular, it spares the patients’ morbidity related to mandibulotomy.
The transoral approach, especially with robotic surgical systems seem likely to offer an alternative approach and refinement of oropharuyngectomy in the future.
Keywords: Advanced oropharyngeal carcinoma, mandibulotomy, transcervical oropharyngectomy.
Current Cancer Therapy Reviews
Title:Transcervical Oropharyngectomy: A Clinically Focused Review
Volume: 11 Issue: 1
Author(s): Yasuhisa Hasegawa
Affiliation:
Keywords: Advanced oropharyngeal carcinoma, mandibulotomy, transcervical oropharyngectomy.
Abstract: The controversial point of treatment for oropharyngeal cancer is the surgical approach and it is in transition, especially for resectable tumors. Transcervical oropharyngectomy with mandibulotomy is an oncologically valid surgical option for resectable T3–T4a oropharyngeal cancers and contraindications for transoral lateral oropharyngectomy. The approach without mandibulotomy allows for simple reconstruction and has a low complication rate. In particular, it spares the patients’ morbidity related to mandibulotomy.
The transoral approach, especially with robotic surgical systems seem likely to offer an alternative approach and refinement of oropharuyngectomy in the future.
Export Options
About this article
Cite this article as:
Hasegawa Yasuhisa, Transcervical Oropharyngectomy: A Clinically Focused Review, Current Cancer Therapy Reviews 2015; 11 (1) . https://dx.doi.org/10.2174/157339471101150706122028
DOI https://dx.doi.org/10.2174/157339471101150706122028 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
EDITORIAL (Hot Topic: “Signal Transduction and Response to Anti-Cancer Therapy”)
Current Signal Transduction Therapy Targeted Drug Delivery to Central Nervous System (CNS) for the Treatment of Neurodegenerative Disorders: Trends and Advances
Central Nervous System Agents in Medicinal Chemistry In Vitro Antitumoral Activity of Palladium(II) and Platinum(II) Complexes with O,O'-Dialkyl Esters of Ethylene-bis(S)-Leucine
Letters in Drug Design & Discovery Targeted Multifunctional Lipid-Based Nanocarriers for Image-Guided Drug Delivery
Anti-Cancer Agents in Medicinal Chemistry Molecular Imaging of Apoptosis with Radio-Labeled Annexin A5 Focused on the Evaluation of Tumor Response to Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry PiWi RNA in Neurodevelopment and Neurodegenerative Disorders
Current Molecular Pharmacology microRNA-133: Expression, Function and Therapeutic Potential in Muscle Diseases and Cancer
Current Drug Targets Role of Liprins in the Regulation of Tumor Cell Motility and Invasion
Current Cancer Drug Targets Interrelationships of Circulating Tumor Cells with Metastasis and Thrombosis: Role of MicroRNAs
Current Pharmaceutical Design The Natural Tumor Suppressor Protein Maspin and Potential Application in Non Small Cell Lung Cancer
Current Pharmaceutical Design Issues in the Psychiatric Screening of Cancer Patients
Current Psychiatry Reviews Anti-Cancer Compounds from Terrestrial and Marine Resources -In silico and Experimental Studies
Current Computer-Aided Drug Design New Therapeutic Platforms for the Treatment of Epithelial and Cutaneous Lesions
Current Drug Delivery Macromolecular Drug Targets in Cancer Treatment and Thiosemicarbazides as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Current Molecularly Targeting Therapies in NSCLC and Melanoma
Anti-Cancer Agents in Medicinal Chemistry PET Tracers Based on Zirconium-89
Current Radiopharmaceuticals Nucleosides, a Valuable Chemical Marker for Quality Control in Traditional Chinese Medicine Cordyceps
Recent Patents on Biotechnology Tailored Angiogenesis Inhibition in Cancer Therapy: Respecting the Heart to Improve the Net Outcome
Current Signal Transduction Therapy Connexins as Precocious Markers and Molecular Targets for Chemical and Pharmacological Agents in Carcinogenesis
Current Medicinal Chemistry Chemosensitization of Prostate Cancer by Modulating Bcl-2 Family Proteins
Current Drug Targets